Cash rewards for sober breath tests show promise in cutting alcohol use
NCT ID NCT06456905
First seen Jul 06, 2026 · Last updated Jul 07, 2026 · Updated 1 time
Summary
This study tests whether giving people rewards for passing breathalyzer tests can help them reduce or stop drinking. Adults who want to quit or cut back on alcohol will use a smartphone app to submit breath samples at set times. Those who consistently show zero alcohol get increasing rewards, while a missed target resets the reward amount. The goal is to see if this simple incentive system boosts sober days.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Contingency Management (behavioral reward program)
- What this could lead to
- If effective, this reward-based approach could offer a simple, medication-free way to help people reduce or stop drinking.
- What could go wrong
- This is a mid-stage trial with 120 participants, so results may not apply to everyone. The reward system may not work for all, and drinking habits could return after the study ends.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
120 people
The number who actually took part.
- Started
-
Jun 2024
- Finished
-
Dec 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 70 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Age 18-70 years * Have consumed 3 or more drinks in once occasion 4 or more times in the previous 30 days 3 * Have the ability to read and speak English * Have the ability to provide written informed consent * Have a breath alcohol value of 0.00 during informed consent * Owns a smartphone with an active service provider that is compatible with the study application. Exclusion Criteria: * Severe alcohol use disorder that our medical staff deems too risky for safe participation; * Significant risk of dangerous alcohol withdrawal, defined as history of seizure due to alcohol withdrawal in the last 12 months and/or expression of concern by the participant about dangerous withdrawal * Anyone aged 71 or older. * Anyone with a suicide attempt in the last 2 years. * Individuals who express concern regarding dangerous withdrawal or who exhibit dangerous withdrawal symptoms. * Individuals who do not test BrAC = 0.00 on the breathalyzer during the baseline visit. * Any other condition that investigators determine a medical or psychiatric condition that would compromise safe study participation.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Alcohol use disorder are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
WSU APPL Research
Spokane, Washington, 99201, United States
-
Washington State University
Spokane, Washington, 99202, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Investigating the Mu:Kappa opioid receptor imbalance in alcohol use disorder
- Identification of cellular and molecular mechanisms involved in the pathophysiology of alcohol use disorder by examination of cerebrospinal fluid
- Intravenous acetate as an adjunctive treatment for alcohol withdrawal in hospitalized patients
- Can a gentle brain current quiet alcohol cravings?
- Brain imaging may expose a shared marker in PTSD and alcohol addiction
- Could a seizure drug curb alcohol withdrawal in trauma wards?